PAPER
Synthesis of L-Pyranosides
IR (neat): 3457 cm–1 (OH).
2993
Melting points were determined with a Yanagimoto micro melting
point apparatus and are uncorrected. IR spectra were measured with
a JASCO FT/IR-8000 spectrometer. HRFAB-MS were recorded
with a JEOL SX-102A. 1H NMR and 13C NMR spectra were record-
ed at 600 MHz with a JEOL GSX-600 spectrometer using TMS as
the internal standard. Chemical shifts were reported in ppm down-
field from TMS. Optical rotations were measured with a JASCO
DIP-370 in a 1 dm cell. Analytical and preparative TLC was con-
ducted on precoated TLC plates (silica gel 60 F254, Merck). Column
chromatography was performed using Merck silica gel 60 N (100–
210 mm). All anhydrous solvents were purified according to stan-
dard methods.
1H NMR (600 MHz, CDCl3): d = 7.35–7.09 (15 H, m, C6H5), 4.85
(1 H, d, J = 12.1 Hz, PhCH2), 4.76 (1 H, d, J = 8.0 Hz, H-1), 4.74 (1
H, d, J = 12.1 Hz, PhCH2), 4.58 (1 H, d, J = 12.1 Hz, PhCH2), 4.54
(1 H, d, J = 12.1 Hz, PhCH2), 4.36 (1 H, d, J = 11.8 Hz, PhCH2),
4.22 (1 H, d, J = 11.8 Hz, PhCH2), 3.95 (1 H, ddd, J = 1.4, 4.7, 7.2
Hz, H-5), 3.82 (1 H, dd, J = 7.2, 11.3 Hz, H-6), 3.79 (1 H, dd,
J = 3.3, 3.6 Hz, H-3), 3.59 (1 H, dd, J = 3.3, 8.0 Hz, H-2), 3.56 (1
H, dd, J = 4.7, 11.3 Hz, H-6¢), 3.55 (3 H, m, CH3), 3.38 (1 H, dd,
J = 1.4, 3.6 Hz, H-4).
13C NMR (150 MHz, CDCl3): d = 138.7, 138.2, 137.5, 128.4, 128.3,
128.1, 128.0, 127.9, 127.8, 127.7, 127.5 (C6H5), 102.0 (C-1), 76.4
(C-3), 75.0 (C-2), 74.5 (C-4), 73.5, 73.4, 73.1 (PhCH2), 72.2 (C-5),
62.4 (C-6), 56.7 (CH3).
The TBDMS ether 1e was prepared from 1d by the usual silylation
procedure.
HRMS (EI): m/z calcd for C28H32O6: 464.2198; found: 464.2184.
Methyl 2,3-Di-O-benzyl-4-O-[tert-butyl(dimethyl)silyl]-6-
deoxy-a-D-threo-hex-5-enopyranoside (1e)
[a]D26 +2.23 (c = 0.73, CHCl3).
IR (neat): 1667 cm–1 (C=C).
Methyl 2,3-Di-O-benzyl-4-O-[tert-butyl(dimethyl)silyl]-b-L-
idopyranoside (2e)
[a]D21 +20.5 (c = 0.47, CHCl3).
1H NMR (600 MHz, CD3OD): d = 7.33–7.23 (10 H, m, C6H5), 4.86
(1 H, d, J = 11.3 Hz, PhCH2), 4.80 (1 H, d, J = 1.7 Hz, H-6), 4.78 (1
H, d, J = 3.3 Hz, H-1), 4.76 (1 H, d, J = 11.3 Hz, PhCH2), 4.67 (1
H, d, J = 11.6 Hz, PhCH2), 4.66 (1 H, d, J = 1.7 Hz, H-6¢), 4.63 (1
H, d, J = 11.6 Hz, PhCH2), 4.00 (1 H, d, J = 8.3 Hz, H-4), 3.66 (1
H, dd, J = 3.3, 9.3 Hz, H-2), 3.63 (1 H, dd, J = 8.3, 9.3 Hz, H-3),
3.40 (3 H, s, CH3), 0.94 (9 H, s, t-C4H9), 0.06 (3 H, s, CH3), 0.04 (3
H, s, CH3).
13C NMR (150 MHz, CD3OD): d = 157.7 (C-5), 140.2, 139.5, 129.4,
129.2, 129.1, 128.9, 128.5 (C6H5), (100.0) (C-1), (97.6) (C-6),
(82.9) (C-3), (81.3) (C-2), (76.5) (C-4), 74.2, 73.6 (PhCH2), 55.7
(CH3), 26.4 [C(CH3)3], 19.0 [C(CH3)3], –4.29 [Si(CH3)2].
IR (neat): 3451 cm–1 (OH).
1H NMR (600 MHz, CDCl3): d = 7.33–7.24 (10 H, m, C6H5), 4.79
(1 H, d, J = 11.3 Hz, PhCH2), 4.70 (1 H, d, J = 12.1 Hz, PhCH2),
4.69 (1 H, d, J = 11.3 Hz, PhCH2), 4.59 (1 H, d, J = 12.1 Hz,
PhCH2), 4.52 (1 H, d, J = 3.8 Hz, H-1), 3.94–3.89 (1 H, m, H-5),
3.88–3.84 (3 H, m, H-3, H-6, H-6¢), 3.81 (1 H, dd, J = 5.5, 7.7 Hz,
H-4), 3.47 (3 H, s, CH3), 3.45 (1 H, dd, J = 3.8, 7.9 Hz, H-2), 0.86
(9 H, s, t-C4H9), 0.05 (3 H, s, CH3), 0.02 (3 H, s, CH3).
13C NMR (150 MHz, CDCl3): d = 138.6, 138.2, 137.5, 128.5, 128.4,
128.3, 128.2, 128.1, 128.0, 127.9 (C6H5), 100.1 (C-1), 78.5 (C-3),
78.0 (C-2), 74.8 (C-5), 74.8, 73.7 (PhCH2), 71.9 (C-4), 62.9 (C-6),
57.0 (CH3), 25.8 [C(CH3)3], 18.0 [C(CH3)3], –4.67 [Si(CH3)2].
HRMS (EI): m/z calcd for C27H38O5Si: 470.2489; found: 470.2480.
HRMS (FAB-NBA + NaI): m/z calcd for C27H40O6SiNa: 511.2492;
found: 511.2492.
Hydroboration/Oxidation; Methyl 2,3,4-Tri-O-benzyl-b-L-
idopyranoside (2a) and Methyl 2,3,4-Tri-O-benzyl-a-D-glucopy-
ranoside (3a); Typical Procedure
Dimethyl 2,3,4-Tri-O-benzyl-b-L-idopyranosiduronate (4)
To a solution of 2a (120 mg, 0.26 mmol) in anhyd acetone (3 mL)
was added a solution of CrO3 (69.7 mg, 0.70 mmol) in 3.5 M H2SO4
(1 mL) at 0 °C. The solution was stirred at 0 °C for 10 min and then
at r.t. for 1 h. After filtration, the filtrate was extracted with CHCl3,
and the extract was dried (Na2SO4) and evaporated. The crude car-
boxylic acid (104.5 mg, 0.22 mmol) thus obtained was dissolved in
CH2Cl2 (2 mL), and an excess amount of diazomethane in Et2O was
added to the mixture. After stirring the mixture at 0 °C for 90 min,
the solvent was evaporated. The residue was purified by silica gel
chromatography (hexane–EtOAc, 10:1) to give 76.3 mg of 4 (60%);
[a]D26 +29.0 (c = 1.10, CHCl3).
To a solution of 1a (32.0 mg, 0.07 mmol) in anhyd THF (1 mL) was
added a 1.08 M solution of borane in THF (0.66 mL, 0.72 mmol) at
0 °C, and the mixture was stirred at 0 °C for 1 h. Then, 30% H2O2
(1 mL) and aq 2 N NaOH (1 mL) were successively added and the
mixture was stirred for 30 min and extracted with EtOAc. The
EtOAc extract was washed with aq sat. NH4Cl, dried (Na2SO4), and
evaporated. Purification by chromatography on silica gel (hexane–
EtOAc, 2:1) gave 28.4 mg of the product (85%, 2a:3a = 11:1).
Methyl O-2,3,4-Tri-O-benzyl-a-D-galactopyranoside (3b)
[a]D24 +10.8 (c = 0.76, CHCl3).
IR (neat): 3436 cm–1 (OH).
IR (neat): 1688 cm–1 (C=O).
1H NMR (600 MHz, CDCl3): d = 7.26–7.15 (15 H, m, C6H5), 4.68
(1 H, d, J = 12.7 Hz, PhCH2), 4.58 (1 H, d, J = 12.7 Hz, PhCH2),
4.57 (1 H, d, J = 12.1 Hz, PhCH2), 4.50–4.48 (3 H, m, H-5, PhCH2),
4.41 (1 H, d, J = 12.1 Hz, PhCH2), 4.23 (1 H, d, J = 3.6 Hz, H-1),
3.97–3.95 (1 H, dd, J = 5.5, 7.6 Hz, H-3), 3.65 (3 H, s, CH3), 3.61
(3 H, dd, J = 3.6, 5.5 Hz, H-2), 3.41–3.39 (4 H, m, H-4, CH3).
13C NMR (150 MHz, CDCl3): d = 169.5 (C=O), 138.5, 138.0, 137.9,
128.5, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6
(C6H5), 100.9 (C-1), 75.7 (C-3), 74.5 (C-4), 73.7, 73.5, 72.9
(PhCH2), 56.9 (CH3), 51.9 (COCH3).
1H NMR (600 MHz, CDCl3): d = 7.42–7.25 (15 H, m, C6H5), 4.97
(1 H, d, J = 11.7 Hz, PhCH2), 4.89 (1 H, d, J = 11.7 Hz, PhCH2),
4.84 (1 H, d, J = 12.0 Hz, PhCH2), 4.75 (1 H, d, J = 11.7 Hz,
PhCH2), 4.71–4.68 (2 H, m, PhCH2, H-1), 4.63 (1 H, d, J = 12.0 Hz,
PhCH2), 4.05 (1 H, dd, J = 3.7, 10.0 Hz, H-2), 3.94 (1 H, dd, J = 2.7,
10.0 Hz, H-3), 3.87 (1 H, d, J = 2.7 Hz, H-4), 3.74–3.68 (2 H, m, H-
6, H-6¢), 3.45–3.52 (1 H, m, H-5), 3.36 (3 H, s, CH3).
13C NMR (150 MHz, CDCl3): d = 138.5, 138.2, 138.0, 128.4, 128.3,
128.2, 127.9, 127.8, 127.7, 127.4 (C6H5), 98.8 (C-1), 79.1 (C-3),
76.5 (C-2), 75.1, 74.4, 72.9 (PhCH2), 73.6 (C-4), 70.3 (C-5), 62.4
(C-6), 55.4 (CH3).
HRMS (EI): m/z calcd for C29H32O7: 492.2148; found, 492.2132.
HRMS (EI): m/z calcd for C28H32O6: 464.2199; found: 464.2204.
Dimethyl b-L-Idopyranosiduronate (5)
To a solution of 4 (71.9 mg, 0.15 mmol) in anhyd MeOH (1.5 mL)
was added Pd(OH)2/C (14.4 mg). After stirring the mixture under a
H2 atmosphere for 22 h, the catalyst was removed by filtration. The
Methyl 2,3,4-Tri-O-benzyl-b-L-gulopyranoside (2c)
[a]D23 +21.1 (c = 0.77, CHCl3).
Synthesis 2004, No. 18, 2991–2994 © Thieme Stuttgart · New York